Abstract
Recently, an apparent rise in the number of cases attributed to community-acquired Clostridium difficile infection has led researchers to explore additional sources of infection. The finding of C. difficile in food animals and retail meat has raised concern about potential food-borne and occupational exposures. The objective of this study was to compare C. difficile isolated from a closed population of healthy individuals consisting of both humans and swine in order to investigate possible food safety and occupational risks for exposure. Using a multistep enrichment isolation technique, we identified 11.8% of the human wastewater samples and 8.6% of the swine samples that were positive for C. difficile. The prevalences of C. difficile in swine production groups differed significantly (P < 0.05); however, the prevalences in the two human occupational group cohorts did not differ significantly (P = 0.81). The majority of the human and swine isolates were similar based on multiple typing methods. The similarity in C. difficile prevalence in the human group cohorts suggests a low occupational hazard, while a greatly decreased prevalence of C. difficile in later-stage swine production groups suggests a diminished risk for food-borne exposure. The similarity of strains in the two host species suggests the possibility of a common environmental source for healthy individuals in a community setting.
INTRODUCTION
Clostridium difficile has been recognized as one of the leading bacterial causes of nosocomial diarrhea and pseudomembranous colitis in hospitals and nursing homes since the 1970s. The emergence of community-acquired cases has recently led researchers to search for additional sources of infections (11, 18). Patients with no recent history of prior hospitalization are typically classified as community-acquired cases (7, 32). Several studies have shown that a history of antibiotic use is not only a risk factor for nosocomial infection but also for community-acquired infection (18, 36); however, another study found that 35% of community-acquired cases had no history of hospitalization or antibiotic use (48), and there have been published reports of cases with no history of antibiotic use (8). Some of the other possible sources or risk factors for these community-acquired infections under investigation include food-borne exposure, companion and food animal exposure, environmental exposure, and concurrent use of proton pump inhibitors (2, 12, 13, 21, 28, 35, 38, 39, 41, 50).
Clostridium difficile has been isolated from food animals, including swine, chickens, and cattle (21, 35, 40–42, 50). C. difficile was first discovered in swine in 1980 when gnotobiotic pigs were accidentally exposed to the bacterium (31) and has since been found to be one of the primary agents responsible for diarrhea in piglets (47, 49). The prevalence of C. difficile in piglets has been reported to range from 25.9% (4) to around 50% (6, 33) and even as high as 74% (47). The majority of strains isolated from piglets are toxinotype V, ribotype 078, pulsed-field gel electrophoresis (PFGE) type NAP7 (North American pulsed-field type 7) (15, 25, 35). Some strains isolated from swine have shown as much as 100% similarity to those isolated from humans (21). Retail meats have also proven to be a source for C. difficile (39, 42). The finding of C. difficile in food animals and retail meat raises concern for the potential for both food-borne and occupational exposures. The objective of this study was to compare the prevalence and genotypic characteristics of C. difficile isolated from a closed healthy population consisting of both humans and swine to investigate possible food safety and occupational risks associated with C. difficile in swine.
MATERIALS AND METHODS
Sampling.
Swine composite fecal samples and human composite wastewater samples were collected from a closed, vertically integrated population in the state of Texas. The population consisted of 12 units in different geographical locations that contained both a human and swine population; in addition, there was also a single on-site slaughter plant facility dedicated to the processing of these pigs. There was little movement into or out of the system by either the swine or human population.
The human population consisted of occupational group cohorts of individuals who work with swine (swine workers) and individuals who do not work with swine (nonswine workers). The two occupational cohorts were housed separately, and the only difference between the two populations was their exposure to swine. All individuals had equal opportunity to consume pork produced within the system. The swine population flowed vertically from the farrowing barn to the grower/finisher slabs; thereafter, all finished swine were slaughtered and consumed within the closed agricultural food system. Swine production groups sampled included farrowing, nursery, grower/finisher, and breeding cohorts.
Human and swine composite fecal samples were collected monthly from February 2004 through January 2007. Sampling methods for the swine population have been previously described (33). Composite wastewater grab samples were collected from representative sewage manholes (i.e., directly draining lavatories of the two representative occupational cohorts) into 50-ml tubes. The wastewater systems were closed and not affected by rainwater or surface runoff. The sampling locations were chosen to differentiate between the occupational cohorts, and typically 3 swine worker wastewater samples and 3 nonswine worker wastewater samples were collected from each of the 13 units. Samples were stored on ice and shipped to the Food and Feed Safety Research Unit (FFSRU) laboratory, Agricultural Research Service (ARS), U.S. Department of Agriculture (USDA), College Station, TX. Upon arrival, the wastewater samples were stirred to ensure uniformity, and then 4 ml was placed into a 5-ml tube containing 1 ml of sterile glycerol and stored at −80°C.
Isolation of bacteria.
Isolation of C. difficile from swine fecal samples was performed utilizing an enrichment procedure, alcohol shock treatment, and restrictive medium technique previously described (33). Isolation of bacteria from the more-diluted human wastewater samples was performed in a similar manner as for the swine samples except for one modification during the plating step. In an anaerobic chamber, 1 g of wastewater sample was added to a 15-ml tube containing 2 ml of 96% ethanol. The samples were aerobically agitated for 50 min and then centrifuged at 3,800 × g for 10 min. In an anaerobic chamber, the supernatant was removed from the tubes, and the sediment was suspended in 5 ml of cycloserine-cefoxitin-fructose broth (CCFB) (33). The enriched samples were incubated for 7 days anaerobically at 37°C. On the seventh day, 5 ml of 96% ethanol was added to the tubes anaerobically, and the tubes were centrifuged aerobically at 3,800 × g for 10 min. The supernatant was removed anaerobically, the sediment was suspended in 200 μl of sterile deionized water, and 200 μl of the suspended sediment was spread onto a cycloserine-cefoxitin-fructose agar (CCFA) plate (Anaerobe Systems, Walnut, CA). The plates were incubated anaerobically at 37°C and checked daily for growth for 5 days.
Molecular methods.
Isolation of the DNA was accomplished by the QIAamp DNA minikit (Qiagen Sciences, Germantown, MD). PCR analysis for the presence of toxin genes, tcdC gene deletion, binary toxin gene, and toxinotyping for isolates from both the human and swine wastewater samples were performed using methods previously described (23, 24, 26). Pulsed-field gel electrophoresis (PFGE) was performed using a modified technique utilized by the U.S. Centers for Disease Control and Prevention (26).
Statistical methods.
Descriptive statistics, both within and between host species, were generated using cross tabulations by year, month, season, location, and production group/occupational group cohort. Multilevel mixed-effect logistic regression (Stata SE Release 10.1; Stata Corp., College Station, TX), including random intercepts for unit and year in the model to account for the dependence of responses on location and time, was used to explore risk factor associations both within and between host species.
RESULTS
Swine descriptive statistics.
A total of 2,936 swine composite samples were tested, and 252 of the samples (8.6%) were culture positive for C. difficile. The prevalence of C. difficile varied across the 3 years from 8.6% in 2004 to 3.9% in 2005 with a high of 13.6% in 2006. The prevalence was significantly (P < 0.05) different among the production groups with the highest prevalence (24.9%) identified in the farrowing barn and the lowest prevalence (2.7%) identified in the grower/finisher swine. The prevalence did not differ significantly (P = 0.96) between the seasons. The average monthly prevalence was 8.5% and varied from a high of 12.1% in September to a low of 5.0% in July. Across the 12 swine production units, the prevalence varied from 14.6% to 0.9%. Units one, five, six, and seven had the highest prevalence, and all four of these units were farrow-to-finish units (Table 1).
Table 1.
General risk factor | Specific risk factora | C. difficile prevalence (%) in swine (no. of samples) | 95% CIb (%) for prevalence in swine | C. difficile prevalence (%) in human wastewater (no. of samples) | 95% CI (%) for prevalence in human wastewater |
---|---|---|---|---|---|
Year | 2004 | 8.6 (86) | 6.9–10.3 | 10.0 (82) | 8.0–12.1 |
2005 | 3.9 (39) | 2.7–5.1 | 18.6 (150) | 15.9–21.3 | |
2006 | 13.6 (127) | 11.4–15.8 | 5.8 (39) | 4.1–7.6 | |
Production group | Farrowing | 24.9 (175) | 21.7–28.1 | ||
Nursery | 5.1 (14) | 2.5–7.7 | |||
Breeding | 4.3 (26) | 2.7–5.9 | |||
Grower/finisher | 2.7 (37) | 1.9–3.6 | |||
Occupational group | Swine worker | 12.0 (131) | 10.1–14.0 | ||
cohort | Nonswine worker | 11.6 (140) | 9.8–13.5 | ||
Season/month | |||||
Fall | September | 12.1 (49) | 7.9–16.3 | 10.1 (21) | 6.0–14.2 |
October | 7.6 (38) | 4.1–11.0 | 10.6 (21) | 6.3–14.9 | |
November | 7.3 (34) | 4.1–10.6 | 8.3 (16) | 4.4–12.2 | |
Fall | 9.0 (63) | 6.7–11.1 | 9.7 (58) | 7.3–12.1 | |
Winter | December | 7.6 (44) | 3.9–11.3 | 15.8 (29) | 10.5–21.0 |
January | 8.9 (46) | 5.5–12.4 | 11.4 (23) | 7.0–15.8 | |
February | 9.3 (32) | 5.7–12.9 | 4.9 (9) | 1.8–8.0 | |
Winter | 8.7 (61) | 6.6–10.8 | 10.7 (61) | 8.1–13.2 | |
Spring | March | 8.4 (50) | 4.9–11.8 | 14.9 (29) | 9.9–20.0 |
April | 8.7 (44) | 5.4–12.1 | 11.3 (20) | 6.6–16.0 | |
May | 8.3 (67) | 5.1–11.5 | 22.2 (43) | 16.3–28.0 | |
Spring | 8.5 (69) | 6.6–10.4 | 16.3 (92) | 13.2–19.3 | |
Summer | June | 10.7 (41) | 7.0–14.3 | 6.1 (12) | 2.8–9.5 |
July | 5.0 (35) | 2.1–7.9 | 13.5 (24) | 8.4–18.5 | |
August | 8.4 (43) | 4.8–12.0 | 13.1 (24) | 8.2–18.0 | |
Summer | 8.2 (59) | 6.2–10.2 | 10.8 (60) | 8.2–13.4 | |
Unit | 1 (F) | 14.6 (59) | 11.3–18.4 | 10.6 (17) | 6.3–16.4 |
2 (G) | 6.5 (8) | 2.8–12.3 | 13.0 (21) | 8.2–19.1 | |
3 (F) | 1.9 (7) | 0.8–4.0 | 15.7 (26) | 10.5–22.1 | |
4 (G) | 2.5 (3) | 0.5–7.3 | 10.8 (23) | 7.0–15.8 | |
5 (F) | 10.9 (49) | 8.2–14.2 | 12.8 (20) | 8.0–19.1 | |
6 (F) | 14.5 (57) | 11.2–18.4 | 9.1 (17) | 5.4–14.2 | |
7 (F) | 11.6 (47) | 8.6–15.1 | 17.2 (28) | 11.7–23.9 | |
8 (G) | 4.6 (6) | 1.7–9.8 | 9.9 (21) | 6.2–14.7 | |
9 (G) | 1.6 (2) | 0.2–5.7 | 13.7 (19) | 8.4–20.5 | |
10 (G) | 0.9 (1) | 0.02–4.8 | 10.1 (20) | 6.3–15.2 | |
11 (G) | 4.1 (5) | 1.3–9.3 | 14.1 (29) | 9.6–19.6 | |
12 (G) | 4.1 (8) | 1.8–8.0 | 7.6 (13) | 4.1–12.6 | |
13 (S) | 10.8 (17) | 6.4–16.7 | |||
Total | 8.6 (252) | 7.6–9.6 | 11.8 (271) | 10.5–13.1 |
The unit type is shown in parentheses after the unit number as follows: F, farrow-to-finish unit; G, grower-finisher; S, slaughter plant.
95% CI, 95% confidence interval.
Human descriptive statistics.
There were 2,292 human wastewater samples tested, and 271 of the samples (11.8%) were culture positive for C. difficile. The prevalence of C. difficile varied across the 3 years from 10.0% in 2004, 18.6% in 2005, and 5.8% in 2006. There was no significant difference (P = 0.42) in the prevalence of C. difficile between the swine worker and nonswine worker occupational group cohorts. The prevalence of C. difficile differed significantly (P < 0.05) between the seasons, with a higher prevalence (16.3%) during the spring, which included the months of March, April, and May. The average monthly prevalence was 11.6% and varied from a high of 22.2% in May to a low of 4.9% in February. Across the units, the prevalence varied from a low of 7.6% in unit 12 to a high of 17.2% in unit 7 (Table 1).
Swine molecular results.
The majority of the swine isolates (n = 236; 93.7%) were toxinotype V. The other toxinotypes found included 7 toxinotype V-like isolates, 7 toxinotype XI isolates, and 2 toxinotype 0 isolates (Table 2). Sixty-six (26.2%) of the isolates were PFGE type NAP7 (North American pulsed-field type 7). The most commonly identified PFGE pattern (173 isolates; 68.7%) was a NAP7 variant pattern that was 90.5% similar to type NAP7 by dendrogram analysis.
Table 2.
Toxinotype | No. of isolates from: |
Toxin genesa | tcdC gene deletion (bp) | Binary toxin | |
---|---|---|---|---|---|
Swine | Humans | ||||
0 | 2 | 26 | A+ B+ | 0 | Negative |
III | 0 | 4 | A+ B+ | 18 | Positive |
V | 236 | 229 | A+ B+ | 39 | Positive |
V-like | 7 | 7 | A− B+ | 39 | Positive |
XI | 7 | 5 | A− B− | 39 | Positive |
A+ B+, A positive and B positive; A−, A negative; A− B−, A negative and B negative.
Human molecular results.
Toxinotyping by PCR revealed 229 (84.5%) of the human wastewater isolates as toxinotype V, 26 (10.7%) as toxinotype 0, 7 (2.6%) as toxinotype V-like, 5 (1.8%) as toxinotype XI, and 4 (1.5%) as toxinotype III (Table 2). The majority of the human isolates were of either the PFGE type NAP7 (23.6%) or the NAP7 variant (66.8%) pattern.
Multilevel mixed-effect logistic regression models within host species.
A multilevel mixed-effect logistic regression model for the swine population showed that production group added significantly (P < 0.001) to the model, whereas season (P = 0.83) and month (P = 0.31) were not important. A large component of the variance for C. difficile prevalence initially attributed to unit-to-unit differences was instead explained by the two major production group types housed across the units (i.e., farrow-to-finish units versus grower-to-finisher units). In the intercept-only model, 54.4% of the variance was attributed to the unit, whereas in the final model that included production groups only, 32.3% of the variance was attributed to the unit. The multilevel mixed-effect logistic regression model for the human population identified that season (P < 0.01) was significant in the model; however, occupational group cohort was not important (P = 0.93).
Multilevel mixed-effect logistic regression model across host species.
A multilevel mixed-effect model was used to test the association between the fixed factors of host species or swine production group/human occupational group cohort (colinear/nested within host species), season, month, and the interaction of these factors. Either host species (P = 0.05) or swine production group/human occupation group cohort (P < 0.001) were significant predictors of C. difficile prevalence. The season (P = 0.16) and month (P = 0.08) were not significant predictors. However, when season was forced into the model with either host species or production group/group cohort, we found that both factors became highly significant (P < 0.001). The interaction terms of host species and season were also significant (P < 0.05); however, the interaction term of production group/group cohort and season were not significant (P = 0.06) (Table 3).
Table 3.
Intercept or risk factor | LRT χ2; P value (df)b | Category | Coefficient | Adjusted odds ratio | 95% confidence interval for the odds ratio |
---|---|---|---|---|---|
Intercept | −2.57 | ||||
Risk factors | |||||
Host species | 3.98; 0.05 (1) | Swine (referent) | |||
Human | 0.39 | 1.48 | 1.01–2.17 | ||
Season | 0.45; 0.93 (3) | Winter (referent) | |||
Spring | −0.04 | 0.96 | 0.67–1.38 | ||
summer | −0.03 | 0.97 | 0.66–1.41 | ||
Fall | 0.07 | 1.07 | 0.74–1.56 | ||
Host species and season | 9.14; 0.03 (3) | Swine-winter | |||
interaction | Human-winter | ||||
Swine-spring | |||||
Human-spring | 0.56 | 1.75 | 1.06–2.91 | ||
Swine-summer | |||||
Human-summer | 0.06 | 1.06 | 0.62–1.81 | ||
Swine-fall | |||||
Human-fall | −0.15 | 0.86 | 0.50–1.46 |
A likelihood ratio test (LRT) of random- vs. fixed-effect logistic regression: χ22 = 37.62; P < 0.00001. In the model we used, host species, season, and the interaction of host species and season were treated as the fixed factors, and unit and time were treated as the random effects.
The chi-square values are from an LRT [2(log likelihood in the full model − log likelihood of the reduced model)], used to test the contribution of a subset of parameters to the model.
DISCUSSION
The population used to explore the hypotheses in this study is unique because it was closed, with little movement of the two host species in or out of the system, and it contained an integrated set of occupational or production cohorts. Previously published studies regarding potential for transmission of Clostridium difficile between food animals and humans have compared isolates arising from completely separate populations (5, 10, 14, 25). This is the first study to explore the potential transmission of C. difficile between food animals and humans in the same closed population. This is also the first study to assess the occupational risk of C. difficile infection from food animals, specifically, from human exposure to swine.
The prevalence of C. difficile among the swine production groups was compared in order to determine the potential risk of human infection due to food-borne exposure. C. difficile is known to cause diarrhea and pseudomembranous colitis in piglets (43); however, little is known about the presence of this bacterium in the other swine production groups. Consistent with other published studies, the highest prevalence of C. difficile was identified in samples from the farrowing barn (3, 49). A much lower prevalence of C. difficile was isolated from the grower/finisher pigs (Table 1), and this may be indicative of a lowered food-exposure risk in slaughter-ready pigs. These data are supported by two recent studies that explored the prevalence of C. difficile in late-stage production groups and did not isolate the bacteria from finishing pigs (45) or pigs at slaughter (19). The decreasing prevalence of C. difficile with the age of the pig has also been reported in another study that found prevalence significantly declined with piglet age in piglets sampled on days 2, 7, 30, 44, and 62 (47). At the farm level, the highest prevalence of C. difficile in swine was identified in the farrow-to-finish units in comparison with the grower-finisher units (Table 1). Using multilevel mixed-effect logistic regression models, we identified that this can mostly be explained by the high prevalence of C. difficile among the piglets in the farrowing barn.
An overall C. difficile prevalence of 11.8% was estimated among the human composite wastewater samples. There has been no other previously published data regarding C. difficile in human wastewater. The prevalence in the human wastewater samples was higher than expected; 3% of healthy adults are estimated to be carriers of C. difficile (30), and our samples were derived from primarily asymptomatic individuals and heavily diluted with domestic potable water. However, since the samples were aggregated rather than individual samples and our technique included enrichment steps, this may help to explain the higher prevalence. It is important to note that since we used aggregate samples, the estimates of prevalence are not representative of individual prevalence values for either humans or swine. Another potential reason the prevalence in the human wastewater samples is higher than expected is that the dynamics of bacterial growth within wastewater is unknown. Wastewater samples may contain components that enhance or hinder the survival of C. difficile. C. difficile has been isolated from chlorinated tap water at a very low prevalence and from untreated water in lakes and streams at a much higher prevalence (2). The prevalence of C. difficile found in the wastewater samples in this study may reflect the background level of C. difficile found in untreated sewage.
The risk of acquiring C. difficile from occupational exposure to swine was assessed by comparing the prevalence of C. difficile in human wastewater samples arising from each of the swine worker and nonswine worker group cohorts. No significant difference in prevalence was identified between the occupational group cohorts. Although a background level of C. difficile may exist in the wastewater samples, this level would be equivalent across the occupational groups. The only difference between the two populations is their occupational exposure to swine; therefore, we would conclude that any differences in C. difficile prevalence in the wastewater samples between the two populations would be attributable to swine exposure. This is the first study to assess the risk of occupational exposure to swine and C. difficile infection. Elsewhere, it has been shown that there is an increased risk of occupational exposure to C. difficile for health care workers in a clinical setting (4, 9, 44). There was also no difference in the prevalence of C. difficile in the human wastewater samples compared across unit types (i.e., farrow-to-finish units versus grower-to-finisher units). Units with a high prevalence in swine did not necessarily have a high prevalence in humans. To illustrate, unit 3, which had the lowest prevalence among the farrow-to-finish units for swine, had the second highest prevalence for the human wastewater samples (Table 1). This provides further evidence that there is little or no occupational risk of C. difficile infection arising from direct exposure to swine.
A significantly (P < 0.05) increased prevalence of C. difficile in wastewater was identified during the spring; this included the months of March, April, and May. Seasonal trends in bacterial carriage are not unusual, and there have been conflicting results regarding seasonal trends of C. difficile in the hospital setting (29, 37, 46). Differences in seasonal trends noted among previous studies may be due to variations in the study populations or geography. Importantly, differences in seasonal trends between host species in this study may be due to exposure to environmental sources of C. difficile and differences in these environments among the host species as well.
The majority of both the human wastewater and swine samples were of toxinotype V (Table 2). The finding of toxinotype V as the dominant toxinotype in the swine isolates is consistent with other reports (14, 35). Toxinotype V is not a strain that has been recognized as a major cause of disease in hospitals (34); however, it has been isolated from humans, and some studies have suggested that the rate of toxinotype V isolation from humans is increasing (21). One of the reasons we may have identified a high percentage of toxinotype V isolates among the human samples is because we sampled fecal materials arising from asymptomatic individuals, rather than hospitalized patients. It has been suggested that certain strains of C. difficile may be responsible for community-acquired infection (17), and these may be the strains identified more commonly among the general public.
The two most common PFGE patterns identified among the swine and human isolates were NAP7 and a NAP7 variant. The results from the swine isolates are consistent with other studies that have observed that the majority of isolates from swine are PFGE type NAP7 (21). Studies in human health care facilities have identified PFGE type NAP1 (ribotype 027) to be the virulent strain responsible for most of the recent outbreaks in North America and Europe (1, 20, 27). While no human clinical studies have made explicit mention of NAP7, studies have identified ribotype 078, toxinotype V isolates among human cases, and this is the strain most commonly associated with PFGE type NAP7 (17). Thus, the lack of reporting of NAP7 may simply reflect differences in typing preference across global regions and public health laboratory jurisdictions.
Other studies have also identified a high degree of similarity between human and swine strains of C. difficile (14, 21). The biggest difference between our study and previous studies is that both of our swine and human populations were contained within the same closed system. Previously published studies have compared human and swine strains that arose from different study populations, and often at different times, and this makes it difficult to interpret any association between C. difficile infection in humans and various potential food sources. Similar strain carriage between host species in the same study population provides some evidence for possible transmission between species; however, an equally plausible explanation would be a common environmental source. C. difficile spores can survive in the environment for long periods of time under adverse conditions (22). C. difficile may be a ubiquitous environmental contaminant, and the more places we look for it, the more places we will find it. The finding of anaerobic, Gram-positive bacteria in the environment is not uncommon. A study conducted in South Wales, United Kingdom, isolated C. difficile from various environmental sources, including rivers, lakes, oceans, and soil (2), and Clostridium tetani spores are abundant in the soil and environment, especially in areas surrounding human or animal habitations (16).
This study provides evidence that occupational and food-borne exposures are less likely to be sources of community-acquired C. difficile infections than previously suggested (42). Similar strain carriage identified between the two host species suggests that a common environmental source may be an equally viable hypothesis. Further research is needed to investigate the possible sources of community-acquired C. difficile infections in humans and the component causes needed to propagate the strains associated with clinical disease.
ACKNOWLEDGMENTS
This project was funded in part by National Pork Board grants 06-156 and 10-188 and USDA-CSREES-NRICGP Section 32.1 (Epidemiologic Approaches to Food Safety) grant 2003-35212-13298.
We thank Angela Thompson, Duncan MacCannell, and Ainsley Nicholson at the Centers for Disease Control and Prevention, Atlanta, GA, for their technical assistance with PFGE and PCR toxinotyping protocols, as well as confirming the PFGE and toxinotyping results for a sample of our isolates.
Proprietary or brand names are necessary to report factually on available data; however, the USDA neither guarantees nor warrants the standard of the product, and the use of the name by the USDA implies no approval of the product, and/or exclusion of others that may be suitable.
Footnotes
Present address: MARC, ARS, USDA, P.O. Box 166, Spur 18D, Clay Center, NE 68933.
Present address: Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824.
Published ahead of print on 1 July 2011.
REFERENCES
- 1. Aldeyab M. A., et al. 2011. Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures. Infect. Control Hosp. Epidemiol. 32:210–219 [DOI] [PubMed] [Google Scholar]
- 2. al Saif N., Brazier J. S. 1996. The distribution of Clostridium difficile in the environment of South Wales. J. Med. Microbiol. 45:133–137 [DOI] [PubMed] [Google Scholar]
- 3. Alvarez-Perez S., et al. 2009. Prevalence of Clostridium difficile in diarrhoeic and non-diarrhoeic piglets. Vet. Microbiol. 137:302–305 [DOI] [PubMed] [Google Scholar]
- 4. Arfons L., Ray A. J., Donskey C. J. 2005. Clostridium difficile infection among health care workers receiving antibiotic therapy. Clin. Infect. Dis. 40:1384–1385 [DOI] [PubMed] [Google Scholar]
- 5. Arroyo L. G., et al. 2005. PCR ribotyping of Clostridium difficile isolates originating from human and animal sources. J. Med. Microbiol. 54:163–166 [DOI] [PubMed] [Google Scholar]
- 6. Baker A. A., Davis E., Rehberger T., Rosener D. 2010. Prevalence and diversity of toxigenic Clostridium perfringens and Clostridium difficile among swine herds in the midwest. Appl. Environ. Microbiol. 76:2961–2967 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Barbut F., et al. 2007. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect. Control Hosp. Epidemiol. 28:131–139 [DOI] [PubMed] [Google Scholar]
- 8. Bauer M. P., et al. 2008. Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage-two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea. Neth. J. Med. 66:207–211 [PubMed] [Google Scholar]
- 9. Boaz A., et al. 2000. Pseudomembranous colitis: report of a severe case with unusual clinical signs in a young nurse. Dis. Colon Rectum 43:264–266 [DOI] [PubMed] [Google Scholar]
- 10. Bouvet P. J., Popoff M. R. 2008. Genetic relatedness of Clostridium difficile isolates from various origins determined by triple-locus sequence analysis based on toxin regulatory genes tcdC, tcdR, and cdtR. J. Clin. Microbiol. 46:3703–3713 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Centers for Disease Control Prevention 2008. Surveillance for community-associated Clostridium difficile-Connecticut, 2006. Morb. Mortal. Wkly. Rep. 57:340–343 [PubMed] [Google Scholar]
- 12. Cunningham R., Dale B., Undy B., Gaunt N. 2003. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J. Hosp. Infect. 54:243–245 [DOI] [PubMed] [Google Scholar]
- 13. Dalton B. R., Lye-MacCannell T., Henderson E. A., MacCannell D. R., Louie T. J. 2009. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting. Aliment. Pharmacol. Ther. 29:626–634 [DOI] [PubMed] [Google Scholar]
- 14. Debast S. B., et al. 2009. Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans. Environ. Microbiol. 11:505–511 [DOI] [PubMed] [Google Scholar]
- 15. Duncan P. I., et al. 2009. Yeast, beef and pork extracts counteract Clostridium difficile toxin A enterotoxicity. FEMS Microbiol. Lett. 295:218–225 [DOI] [PubMed] [Google Scholar]
- 16. Edlich R. F., et al. 2003. Management and prevention of tetanus. J. Long Term Eff. Med. Implants 13:139–154 [PubMed] [Google Scholar]
- 17. Goorhuis A., et al. 2008. Emergence of Clostridium difficile infection due to a new hypervirulent strain, PCR ribotype 078. Clin. Infect. Dis. 47:1162–1170 [DOI] [PubMed] [Google Scholar]
- 18. Hirschhorn L. R., Trnka Y., Onderdonk A., Lee M. L., Platt R. 1994. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J. Infect. Dis. 169:127–133 [DOI] [PubMed] [Google Scholar]
- 19. Hoffer E., Haechler H., Frei R., Stephan R. 2010. Low occurrence of Clostridium difficile in fecal samples of healthy calves and pigs at slaughter and in minced meat in Switzerland. J. Food Prot. 73:973–975 [DOI] [PubMed] [Google Scholar]
- 20. Jansen A., et al. 2010. Emergence of Clostridium difficile ribotype 027 in Germany: epidemiological and clinical characteristics. Z. Gastroenterol. 48:1120–1125 [DOI] [PubMed] [Google Scholar]
- 21. Jhung M. A., et al. 2008. Toxinotype V Clostridium difficile in humans and food animals. Emerg. Infect. Dis. 14:1039–1045 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Jump R. L., Pultz M. J., Donskey C. J. 2007. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea? Antimicrob. Agents Chemother. 51:2883–2887 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Kato H., et al. 1998. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J. Clin. Microbiol. 36:2178–2182 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Kato N., et al. 1991. Identification of toxigenic Clostridium difficile by the PCR. J. Clin. Microbiol. 29:33–37 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Keel K., Brazier J. S., Post K. W., Weese S., Songer J. G. 2007. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J. Clin. Microbiol. 45:1963–1964 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Killgore G., et al. 2008. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J. Clin. Microbiol. 46:431–437 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Labbe A. C., et al. 2008. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob. Agents Chemother. 52:3180–3187 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Lefebvre S. L., Reid-Smith R., Boerlin P., Weese J. S. 2008. Evaluation of the risks of shedding Salmonellae and other potential pathogens by therapy dogs fed raw diets in Ontario and Alberta. Zoonoses Public Health 55:470–480 [DOI] [PubMed] [Google Scholar]
- 29. McFarland L. V., Clarridge J. E., Beneda H. W., Raugi G. J. 2007. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system. Clin. Infect. Dis. 45:1141–1151 [DOI] [PubMed] [Google Scholar]
- 30. McFarland L. V., Mulligan M. E., Kwok R. Y., Stamm W. E. 1989. Nosocomial acquisition of Clostridium difficile infection. N. Engl. J. Med. 320:204–210 [DOI] [PubMed] [Google Scholar]
- 31. Nagy J., Bilkei G. 2003. Neonatal piglet losses associated with Escherichia coli and Clostridium difficile infection in a Slovakian outdoor production unit. Vet. J. 166:98–100 [DOI] [PubMed] [Google Scholar]
- 32. Noren T., et al. 2004. Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J. Clin. Microbiol. 42:3635–3643 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Norman K. N., et al. 2009. Varied prevalence of Clostridium difficile in an integrated swine operation. Anaerobe 15:256–260 [DOI] [PubMed] [Google Scholar]
- 34. Paltansing S., et al. 2007. Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005. Clin. Microbiol. Infect. 13:1058–1064 [DOI] [PubMed] [Google Scholar]
- 35. Pirs T., Ocepek M., Rupnik M. 2008. Isolation of Clostridium difficile from food animals in Slovenia. J. Med. Microbiol. 57:790–792 [DOI] [PubMed] [Google Scholar]
- 36. Riley T. V., Cooper M., Bell B., Golledge C. L. 1995. Community-acquired Clostridium difficile-associated diarrhea. Clin. Infect. Dis. 20(Suppl. 2):S263–S265 [DOI] [PubMed] [Google Scholar]
- 37. Riley T. V., O'Neill G. L., Bowman R. A., Golledge C. L. 1994. Clostridium difficile-associated diarrhoea: epidemiological data from Western Australia. Epidemiol. Infect. 113:13–20 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Rodriguez-Palacios A., et al. 2009. Possible seasonality of Clostridium difficile in retail meat, Canada. Emerg. Infect. Dis. 15:802–805 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Rodriguez-Palacios A., Staempfli H. R., Duffield T., Weese J. S. 2007. Clostridium difficile in retail ground meat, Canada. Emerg. Infect. Dis. 13:485–487 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Rodriguez-Palacios A., et al. 2006. Clostridium difficile PCR ribotypes in calves, Canada. Emerg. Infect. Dis. 12:1730–1736 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Simango C., Mwakurudza S. 2008. Clostridium difficile in broiler chickens sold at market places in Zimbabwe and their antimicrobial susceptibility. Int. J. Food Microbiol. 124:268–270 [DOI] [PubMed] [Google Scholar]
- 42. Songer J. G., et al. 2009. Clostridium difficile in retail meat products, USA, 2007. Emerg. Infect. Dis. 15:819–821 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Steele J., Feng H., Parry N., Tzipori S. 2010. Piglet models of acute or chronic Clostridium difficile illness. J. Infect. Dis. 201:428–434 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Strimling M. O., Sacho H., Berkowitz I. 1989. Clostridium difficile infection in health-care workers. Lancet ii:866–867 [DOI] [PubMed] [Google Scholar]
- 45. Thakur S., Putnam M., Fry P. R., Abley M., Gebreyes W. A. 2010. Prevalence of antimicrobial resistance and association with toxin genes in Clostridium difficile in commercial swine. Am. J. Vet. Res. 71:1189–1194 [DOI] [PubMed] [Google Scholar]
- 46. Tvede M., Schiotz P. O., Krasilnikoff P. A. 1990. Incidence of Clostridium difficile in hospitalized children. A prospective study. Acta Paediatr. Scand. 79:292–299 [DOI] [PubMed] [Google Scholar]
- 47. Weese J. S., Wakeford T., Reid-Smith R., Rousseau J., Friendship R. 2010. Longitudinal investigation of Clostridium difficile shedding in piglets. Anaerobe 16:501–504 [DOI] [PubMed] [Google Scholar]
- 48. Wilcox M. H., Mooney L., Bendall R., Settle C. D., Fawley W. N. 2008. A case-control study of community-associated Clostridium difficile infection. J. Antimicrob. Chemother. 62:388–396 [DOI] [PubMed] [Google Scholar]
- 49. Yaeger M., Funk N., Hoffman L. 2002. A survey of agents associated with neonatal diarrhea in Iowa swine including Clostridium difficile and porcine reproductive and respiratory syndrome virus. J. Vet. Diagn. Invest. 14:281–287 [DOI] [PubMed] [Google Scholar]
- 50. Zidaric V., Zemljic M., Janezic S., Kocuvan A., Rupnik M. 2008. High diversity of Clostridium difficile genotypes isolated from a single poultry farm producing replacement laying hens. Anaerobe 14:325–327 [DOI] [PubMed] [Google Scholar]